Related Experiment Video
Updated: Jul 13, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia
Salah Aref1, O Salama, S Shamaa
1Hematology Unit, Clinical Pathology Department, Mansoura Faculty of Medicine, Mansoura, Egypt. salaharef@yahoo.com
Angiogenesis factors like VEGF and MMP-9 are lower in B-lineage acute lymphoblastic leukemia (B-ALL) but higher in B-chronic lymphocytic leukemia (B-CLL). Their levels change with remission, suggesting different roles in these leukemias.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- Angiogenesis is crucial for solid tumor growth and progression.
- The role of angiogenic cytokines in lymphoid leukemia remains unclear.
- Investigating angiogenic profiles in B-cell leukemias is essential for understanding disease mechanisms.
Purpose of the Study:
- To investigate the systemic levels of key angiogenic regulators in B-lineage acute lymphoblastic leukemia (B-ALL) and B-chronic lymphocytic leukemia (B-CLL).
- To compare these levels between patients and healthy controls, and assess changes during remission.
- To explore correlations between angiogenic factors and leukemia cell counts.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of vascular endothelial growth factor (VEGF), tumor necrosis factor-alpha (TNF-alpha), endostatin, and matrix metalloproteinase-9 (MMP-9).
- Measurements were taken at diagnosis and during remission in patients with B-ALL and B-CLL.
- Statistical analyses were performed to compare patient groups with controls and to assess correlations with clinical parameters.
Main Results:
- In B-ALL, serum VEGF and MMP-9 were significantly lower at diagnosis and increased towards control levels in remission.
- In B-CLL, serum VEGF, MMP-9, and TNF-alpha were significantly higher at diagnosis and decreased towards control levels in remission.
- Endostatin levels did not significantly differ from controls in either leukemia type.
- Correlations with platelet counts were observed in B-ALL, while B-CLL showed correlations with white blood cell and bone marrow lymphocyte counts.
Conclusions:
- The regulation of angiogenic factors (VEGF, TNF-alpha, MMP-9) differs significantly between adult B-ALL and B-CLL.
- These findings highlight distinct angiogenic mechanisms driving these two B-cell malignancies.
- Further research into these differences may reveal novel therapeutic targets.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Intracellular Signaling Affects Focal Adhesions
Some...
Differentiation of Common Myeloid Progenitor Cells

